my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
In this paper, the influence of spectral datasets and the method of selection of the corresponding feature vectors on the compression and reconstruction of data is scrutinised. To fulfil this aim, two different sets of reflectance data with the least spectral similarity are selected from different sets of spectral databases and the most optimal eigenvectors are chosen using different strategies. Six and 12 arrangements of eigenvectors obtained from different individual or combined databases are then used for the compression of reflectance spectra of learning sets, as well as those that have not been used in extraction of eigenvectors. The validity of the desired reduced subspaces is assessed by computing the spectral errors between the actual and the reconstructed spectra of samples of learning sets. Moreover, the efficiencies of designed compressed subspaces are evaluated through the numbers of out‐of‐range reconstructed spectra, as well as the spectral and colorimetric deviations between the actual and compressed‐reconstructed reflectance spectra of samples of datasets that were not employed in learning sequence. The results show that in the restricted subspaces, i.e. six‐dimensional subspace, the most effective results are achieved when the reduced subspace is created from a collection of two separate sets of eigenvectors of two different datasets with the maximum degree of dissimilarity, and the reduced spaces that have been made from six eigenvectors of individual datasets lead to higher errors.
| Authors: | Morteza Maali Amiri, Seyed Hossein Amirshahi | |
| Journal: | Coloration Technology | |
| Year: | 2016 | |
| Pages: | n/a | |
| DOI: | 10.1111/cote.12236 | |
| Publication date: | 24-Aug-2016 |
The unfolding landscape of the congenital myasthenic syndromes
Abstract Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is impaired by one or more specific mechanisms. Since the advent of next‐generation sequencing methods, the discovery of novel CMS targets and phenotypes ha ... more
Passive transfer models of myasthenia gravis with muscle‐specific kinase antibodies
Abstract Myasthenia gravis (MG) with antibodies to muscle‐specific kinase (MuSK) is characterized by fluctuating fatigable weakness. In MuSK MG, involvement of bulbar muscles, neck, and shoulder and respiratory weakness are more prominent than in acetylcholine receptor (AChR) MG. MuSK au ... more
Abstract Because of the failure of many promising therapeutics identified in preclinical evaluation, funding sources have established guidelines for increased rigor in animal evaluations. The myasthenia gravis (MG) community of scientists has developed guidelines for preclinical assessme ... more
Smart skin made of recyclable materials may transform medicine and robotics
Smart skin that can respond to external stimuli could have important applications in medicine and robotics. Using only items found in a typical household, researchers have created multi-sensor artificial skin that's capable of sensing pressure, temperature, humidity, proximity, pH, and air ... more
How mercury contamination affects reptiles in the Amazon basin
Mercury contamination in water and on land is of worldwide concern due to its toxic effects on ecosystems and human health. Mercury toxicity is of particular concern to reptiles because they are currently experiencing population declines. Also, reptiles are ideal indicators of mercury conta ... more
Bioengineers Succeed in Producing Plastic Without the use of Fossil Fuels
A team of pioneering South Korean scientists have succeeded in producing the polymers used for everyday plastics through bioengineering, rather than through the use of fossil fuel based chemicals. This groundbreaking research, which may now allow for the production of environmentally consci ... more
Read what you need to know about our industry portal chemeurope.com.
© 1997-2022 LUMITOS AG, All rights reserved
